Advertisement

Topics

GSK appoints Dr Hal Barron as chief scientific officer & president, R&D

07:33 EST 11 Nov 2017 | PharmaBiz

GlaxoSmithKline has announced that Dr Hal Barron has been appointed chief scientific officer and president, R&D, GSK. He has also been appointed as an executive director to the GSK board. Dr Barron will

Original Article: GSK appoints Dr Hal Barron as chief scientific officer & president, R&D

NEXT ARTICLE

More From BioPortfolio on "GSK appoints Dr Hal Barron as chief scientific officer & president, R&D"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...